ColoSense is designed for adults aged 45 to 85 years who are considered at average risk for colorectal cancer.

Time for a gut check. Cases of colorectal cancer are on the rise, surpassing breast and brain cancer as the leading cause of ...

A new blood test for colorectal cancer screening is being implemented in Alabama to improve early detection and reduce deaths ...

CancerCare Manitoba is encouraging more Manitobans to take part in routine colorectal cancer screening, particularly in ...

They told me it was effective, and I knew mailing a Cologuard box back would be pretty dang easy.” Cologuard — a simple way ...

The nationwide rollout, which Labcorp disclosed Monday, comes weeks after the Centers for Medicare and Medicaid Services approved coverage for ColoSense, and the American Cancer Society named the test ...

Labcorp (NYSE: LH), a global leader of innovative and comprehensive laboratory services, today announced the nationwide ...

Natera recently announced that its Signatera minimal residual disease (MRD) test received approval from Japan’s Pharmaceuticals and Medical Devices Agency for use in colorectal cancer patients in the ...

The American Cancer Society released updated guidelines for colorectal cancer screening, adding options for a blood-based ...

The American Cancer Society updates colorectal cancer screening guidelines to improve access and participation, emphasizing ...

A research team at the Korea Institute of Materials Science (KIMS) has developed a plasmonics-based liquid biopsy platform ...

A major European trial has pushed colonoscopy back into the medical spotlight. After 13 years, the NordICC study found that ...